Dilution profile // every instrument, one screen, from SEC filings

Dror Ortho-Design, Inc. (DROR)

CIK 1282980 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGHS-1/A on file 2026-09-16
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
LOWwarrants = 1% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
HIGH+383% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
MEDIUM~10.7 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-03-232026-07-30

Latest: 977.0M shares as of Jul 30, 2026 (10-Q).

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 10.5M underlying shares, as reported Aug 8, 2023 (10-Q).

Reported exercise price: $0.033 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $520,000 as of Jun 30, 2026.

Rough fully diluted estimate: 987.5M = 977.0M O/S + 10.5M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

Convertible debt on the balance sheet: $1.9M as of Jun 30, 2026, tagged only as a company-wide total.

This filer tagged totals without per-note dimensions in its 10-Q filed Jul 30, 2026 →, so per-note terms (maturities, individual conversion prices) live in the exhibit prose and are not parsed here.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding977.0MJul 30, 2026
+ Warrants (aggregate, as tagged) (if exercised)10.5MAug 8, 2023
Fully diluted estimate987.5M+1.1% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

S-1May 28, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-1Feb 9, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 5 executed · 3 registered.

REGISTEREDSep 16, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
EXECUTEDAug 19, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDMay 1, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
REGISTEREDApr 1, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
EXECUTEDMar 4, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
REGISTEREDFeb 3, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
EXECUTEDJan 6, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDDec 8, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDJul 23, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
REGISTEREDJul 14, 2025S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
EXECUTEDJun 18, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDJun 5, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full DROR workspace